Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma
Journal for ImmunoTherapy of Cancer · 2026-06 · 14 (6) · e015100
DOI: 10.1136/jitc-2026-015100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 24.06.2026. Verfasst von Jiahao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Tumor Organoid and Digital Tumor Twin, Department of Biomedical Engin…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Antigens, Neoplasm, CD8-Positive T-Lymphocytes. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Basic Science Center Program of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Renal cell carcinoma (RCC) frequently exhibits favorable responses to immunotherapy, despite a low tumor mutational burden, suggesting a critical role for non-mutational antigens presented by human leukocyte antigen class I in activating CD8 + T cells.
Methods
To systematically identify non-canonical tumor-specific antigens, we developed an integrated proteogenomic approach to RCC samples by combining immunopeptidomics with exome and transcriptome sequencing. We subsequently primed and expanded antigen-reactive T cells in vitro, isolated a panel of antigen-specific T-cell receptors, and characterized their functionality. Finally, we investigated the tumor-killing and regression of non-canonical antigen-reactive T cells using patient-derived tumor-like cell clusters and mouse models.
Results
We discovered a diverse repertoire of non-canonical tumor-specific antigens derived from human endogenous retroviruses (hERVs) and long non-coding RNAs (lncRNAs), many of which were shared across patients. Single-cell RNA sequencing further revealed that T cells reactive to these antigens were enriched within exhausted subsets in the tumor microenvironment, indicative of persistent antigen-specific stimulation. Functionally, T cells engineered to recognize these non-canonical antigens mediated potent tumor cell killing both in vitro and in vivo. Our findings establish hERV-derived and lncRNA-derived antigens as key drivers of RCC immunogenicity and highlight their strong potential as targets for T-cell-based immunotherapy.
Conclusions
Our work is the first to demonstrate that non-canonical antigens drive immunogenicity in low-mutation RCC, thereby resolving a key question in cancer immunology—how tumors with low mutational burden can provoke robust T-cell responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Tumor Organoid and Digital Tumor Twin, Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing, Chin…
- Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Innovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China jzxi@pku.edu.cn bqye@pku.edu.cn yexiongjun@cicams.ac.cn.
Förderung
- National Natural Science Foundation of China
- Basic Science Center Program of the National Natural Science Foundation of China
Zitieren
APA
Wang, J., Zhu, Y., He, X., Yin, S., He, Y., Yao, P., Li, J., Li, X., Shi, P., Qian, R., Xiao, Z., Ye, X., Xi, J. J., & Ye, B. (2026). Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma. Journal for ImmunoTherapy of Cancer, 14(6), e015100. https://doi.org/10.1136/jitc-2026-015100
Vancouver
Wang J, Zhu Y, He X, Yin S, He Y, Yao P, et al. Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 2026;14(6):e015100. doi:10.1136/jitc-2026-015100
BibTeX
@article{Wang2026,
author = {Wang, Jiahao and Zhu, Yihao and He, Xinyu and Yin, Shenyi and He, Yang and Yao, Pengju and Li, Juan and Li, Xuwen and Shi, Peiting and Qian, Renzhi and Xiao, Zhiqing and Ye, Xiongjun and Xi, Jianzhong Jeff and Ye, Buqing},
title = {Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
volume = {14},
number = {6},
pages = {e015100},
doi = {10.1136/jitc-2026-015100}
}
EUVIMED